In drug-resistant cancer cells, however, there is a growing reliance on pyruvate kinase M2 (PKM2)—an isoform of pyruvate kinase that plays a critical role in controlling the balance between glycolysis, the pentose phosphate pathway (PPP), and serine biosynthesis [30,31] (Figure 1). This evidence concerns the gene PKM and cancer.